deltatrials
Completed OBSERVATIONAL NCT02661074

Anisakis Blastocystis Cryptosporidium Fish Prevalence (ABCFish1)

Protists and Nematodes Fish Parasites: From Their Circulation in Ecosystems to Their Impact on Human Health - Prevalence of Fish Allergy in Occupational Settings.

Sponsor: ANSES

Interventions Questionnaire
Updated 8 times since 2017 Last updated: Oct 26, 2016 Started: Nov 30, 2014 Primary completion: Oct 31, 2016 Completion: Oct 31, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02661074, this observational or N/A phase trial focuses on Allergy and Anisakis and remains completed. Sponsored by ANSES, it has been updated 8 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Apr 2018 · 15 months · monthly snapshotCompleted~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2019 · 7 months · monthly snapshotCompleted~Jan 2019 – ~Jan 2021 · 24 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

8 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Jan 2021 — Jul 2024 [monthly]

    Completed

  5. Jan 2019 — Jan 2021 [monthly]

    Completed

Show 3 earlier versions
  1. Jun 2018 — Jan 2019 [monthly]

    Completed

  2. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NANone

  3. Jan 2017 — Apr 2018 [monthly]

    Completed NA

    First recorded

Nov 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • ANSES
  • Institut Pasteur de Lille
  • Région Nord-Pas de Calais, France
  • University Hospital, Lille
Data source: University Hospital, Lille

For direct contact, visit the study record on ClinicalTrials.gov .